MedWatch

Analyst: GN price drop is an obvious opportunity to buy

A price drop of 30 percent since summer makes now an attractive time for investors to buy stock in hearing aid group GN, says analyst.

Photo: GN Store Nord / PR

Since July, GN stock has dropped by 30 percent, and it has now reached an attractive level compared to rivals, assesses Janne Vincent Kjær, senior equity analyst at Danish bank Jyske Bank.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs